These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24465139)

  • 1. New Perspectives of Dyrk1A Role in Neurogenesis and Neuropathologic Features of Down Syndrome.
    Park J; Chung KC
    Exp Neurobiol; 2013 Dec; 22(4):244-8. PubMed ID: 24465139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyrk1A overexpression in immortalized hippocampal cells produces the neuropathological features of Down syndrome.
    Park J; Yang EJ; Yoon JH; Chung KC
    Mol Cell Neurosci; 2007 Oct; 36(2):270-9. PubMed ID: 17720532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome.
    Wegiel J; Dowjat K; Kaczmarski W; Kuchna I; Nowicki K; Frackowiak J; Mazur Kolecka B; Wegiel J; Silverman WP; Reisberg B; Deleon M; Wisniewski T; Gong CX; Liu F; Adayev T; Chen-Hwang MC; Hwang YW
    Acta Neuropathol; 2008 Oct; 116(4):391-407. PubMed ID: 18696092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Link between DYRK1A overexpression and several-fold enhancement of neurofibrillary degeneration with 3-repeat tau protein in Down syndrome.
    Wegiel J; Kaczmarski W; Barua M; Kuchna I; Nowicki K; Wang KC; Wegiel J; Yang SM; Frackowiak J; Mazur-Kolecka B; Silverman WP; Reisberg B; Monteiro I; de Leon M; Wisniewski T; Dalton A; Lai F; Hwang YW; Adayev T; Liu F; Iqbal K; Iqbal IG; Gong CX
    J Neuropathol Exp Neurol; 2011 Jan; 70(1):36-50. PubMed ID: 21157379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies in vitro.
    Coutadeur S; Benyamine H; Delalonde L; de Oliveira C; Leblond B; Foucourt A; Besson T; Casagrande AS; Taverne T; Girard A; Pando MP; Désiré L
    J Neurochem; 2015 May; 133(3):440-51. PubMed ID: 25556849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two key genes closely implicated with the neuropathological characteristics in Down syndrome: DYRK1A and RCAN1.
    Park J; Oh Y; Chung KC
    BMB Rep; 2009 Jan; 42(1):6-15. PubMed ID: 19192387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of DYRK1A in neurodegenerative diseases.
    Wegiel J; Gong CX; Hwang YW
    FEBS J; 2011 Jan; 278(2):236-45. PubMed ID: 21156028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
    Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
    J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neprilysin Is Suppressed by Dual-Specificity Tyrosine-Phosphorylation Regulated Kinase 1A (DYRK1A) in Down-Syndrome-Derived Fibroblasts.
    Kawakubo T; Mori R; Shirotani K; Iwata N; Asai M
    Biol Pharm Bull; 2017; 40(3):327-333. PubMed ID: 28250274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DYRK1a Inhibitor Mediated Rescue of
    Zhu B; Parsons T; Stensen W; Mjøen Svendsen JS; Fugelli A; Hodge JJL
    Front Pharmacol; 2022; 13():881385. PubMed ID: 35928283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?
    Smith B; Medda F; Gokhale V; Dunckley T; Hulme C
    ACS Chem Neurosci; 2012 Nov; 3(11):857-72. PubMed ID: 23173067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease.
    Ryu YS; Park SY; Jung MS; Yoon SH; Kwen MY; Lee SY; Choi SH; Radnaabazar C; Kim MK; Kim H; Kim K; Song WJ; Chung SH
    J Neurochem; 2010 Nov; 115(3):574-84. PubMed ID: 20456003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics.
    Jarhad DB; Mashelkar KK; Kim HR; Noh M; Jeong LS
    J Med Chem; 2018 Nov; 61(22):9791-9810. PubMed ID: 29985601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DYRK1A Protein, A Promising Therapeutic Target to Improve Cognitive Deficits in Down Syndrome.
    Feki A; Hibaoui Y
    Brain Sci; 2018 Oct; 8(10):. PubMed ID: 30332747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyrk1A phosphorylates p53 and inhibits proliferation of embryonic neuronal cells.
    Park J; Oh Y; Yoo L; Jung MS; Song WJ; Lee SH; Seo H; Chung KC
    J Biol Chem; 2010 Oct; 285(41):31895-906. PubMed ID: 20696760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DYRK1A, a Dosage-Sensitive Gene Involved in Neurodevelopmental Disorders, Is a Target for Drug Development in Down Syndrome.
    Duchon A; Herault Y
    Front Behav Neurosci; 2016; 10():104. PubMed ID: 27375444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DYRK1A Inhibitors and Perspectives for the Treatment of Alzheimer's Disease.
    de Souza MM; Cenci AR; Teixeira KF; Machado V; Mendes Schuler MCG; Gonçalves AE; Paula Dalmagro A; André Cazarin C; Gomes Ferreira LL; de Oliveira AS; Andricopulo AD
    Curr Med Chem; 2023; 30(6):669-688. PubMed ID: 35726411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.